$28.91
$0.00 (0.00%)
End-of-day quote: 09/23/2022
NasdaqGS:TXG

10x Genomics (TXG)

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific.

If you are interested in TXG stock information, you might also be interested in competitors like NasdaqGS:FLDM.

With a P/E ratio of 0.00, the stock appears relatively cheap compared to its index ^SPX at the moment.

The market capitalization of 10x Genomics is currently at $3.29 B. This places it among the medium capitalized companies.

The book value reported in the balance sheet results in a P/B ratio of 4.03.

With one share of 10x Genomics investors achieved a dividend of $0.00. This results in a very low dividend yield of 0.00%.

For the risk analysis, the high beta factor should be noted, which is currently at a value of 1.42. The price of the stock NasdaqGS:TXG is therefore subject to relatively strong fluctuations in relation to the overall market.

21.9% of TXG Stocks is owned by insiders.

Since not enough Wall Street analysts have published their estimates, we are unfortunately unable to provide a reliable price target for the TXG stock.

NasdaqGS:TXG has a 52 week range of $128.15 - $208.99 and is currently trading around $28.91.

The low short sale ratio indicated that the value might increase in the foreseeable future.

0
Underperform
1
2
3
4
5
6
7
8
9
10
1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
0.0
Market Cap
3.29B
LT Debt/Cap
0.01%
Price-to-book Ratio
4.03
Earnings
11/08/2022
Dividend
$0.00
Div Yld
0.00%
Dividend Growth
0 Years
Beta
1.42
Short Interest
2.92%
Forecast 1Y
0.00%
Analyst Price Target
$0.00
LTG 5Y
-18.61%
52 week range
$128.15 - $208.99